The dermorphin peptide family

General Pharmacology

Volumn 27, Issue 7, 1996, Pages 1099-1107

  Melchiorri, P ^a   Negri, L ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

analgesics; demorphin; morphine; peptides

Indexed keywords

DERMORPHIN; DERMORPHIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MORPHINE; MU 1 OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; OPIATE AGONIST; PEPTIDE DERIVATIVE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANTINOCICEPTION; BIOSYNTHESIS; BLOOD BRAIN BARRIER; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG TOLERANCE; FROG; GASTROINTESTINAL TRACT; HUMAN; LUNG VENTILATION; MOUSE; NONHUMAN; OPIATE ADDICTION; PRIMATE; PRIORITY JOURNAL; RAT; REVIEW; RODENT; SKIN; STRUCTURE ACTIVITY RELATION;

EID: 0030272919     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02149-3     Document Type: Review

References (95)

1. Aloisi F., Passarelli F., Scotti A., De Carolis A. and Longo V. G. (1982) Central effects of dermorphin. Ann. Istituto Sup. Sanità 18, 1-6.
2. Ambo A., Sasaky Y. and K. Suzuki (1994) Synthesis of carboxy-terminal extension analogs of dermorphin and evaluation of their opioid receptor-binding and opioid activities. Chem. Pharmac. Bull. 42, 888-891.
3. Baldieri Linari M., R. Castellacci and G. Linari (1983) The effect of dermorphin on exocrine pancreatic secretion of the rat. Ital. J. Gastroenterol. 15, 177-180.
4. Banks W. A. and Kastin A. J. (1990) Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259, E1-E10.
5. Barrera C. M., Banks W. A. and Kastin A. J. (1989) Passage of Tyr-MIF-1 from blood to brain. Brain Res. Bull. 23, 439-442.
6. Basso N., Marcelli M., Ginaldi A. and DeMarco M. (1985) Intrathecal dermorphin in post-operative analgesia. Peptides 6, 177-179.
7. Braga P. G., Tienco M., Biella G., Dall'Oglio G. and Franceschini F. (1984) Dermorphin, a new peptide from amphibian skin, inhibits the nociceptive thalamic neurons firing rate evoked by noxious stimuli. Neurosci. Lett. 52, 165, 169.
8. Broccardo M. (1985) Development of tolerance to the effect of dermorphin on gastric emptying in the rat. Pharmac. Res. Commun. 17, 345-350.
9. Broccardo M. (1987a) Effect of dermorphin on body temperature in rats. Pharmac. Res. Commun. 19, 713-721.
10. Broccardo M. (1987b) Pituitary-adrenal mediation of dermorphin-induced inhibition of gastric emptying in rats. Eur. J. Pharmac. 142, 151-154.
11. Broccardo M., Erspamer V., Falconieri Erspamer G., Improta G., Linari G., Melchiorri P. and Montecucchi P. C. (1981) Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin. Br. J. Pharmac. 73, 625-631.
12. Broccardo M., Improta G. (1985) Cross-tolerance between dermorphin and morphine to analgesia and catalepsy in rats. Peptides 6, 165-169.
13. Broccardo M., Improta G., Nargi M. and Melchiorri P. (1982) Effects of dermorphin on gastrointestinal transit in rats. Regul. Peptides 4, 91-96.
14. Broccardo, M., Improta G., Negri L. and Melchiorri P. (1985) Tolerance and physical dependence induced by dermorphin in rats. Eur. J. Pharmac. 110, 55-61.
15. Buffa R., Solcia E., Magnoni E., Rinaldi G., Negri L. and Melchiorri P. (1982) Immunohistochemical demonstration of a dermorphin-like peptide in rat brain. Histochemistry 76, 273-276.
16. 2]dermorphin tetrapeptide analogs and morphine in rats. Br. J. Pharmac. 95, 15-22.
17. 2]dermorphin tetrapeptide analogs and morphine in mice. Pharmac. Biochem. Behav. 31, 439-444.
18. Darlak K., Grzonka Z., Salvadori S. and Tomatis R. (1987) Synthesis and biological activity of some cyclic dermorphins. Polish J. Chem. 62, 445-450.
19. De Castiglione R., Faoro F., Perseo G., Piani S., Santangelo F. and Melchiorri P. (1981) Synthetic peptides related to dermorphins. I. Synthesis and biological activities of the shorter homologues and of analogues of the heptapeptides. Peptides 2, 265-269.
20. Degli Uberti E. C., Petraglia F., Bondanelli M., Guo A. L., Valentini A., Salvadori S., Criscuolo M., Nappi R. E. and Genazzani A. R. (1995) Involvement of μ-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats. J. Endocr. Invest. 18, 1-7.
21. Degli Uberti, E. C., Trasforini G., Salvadori S., Margutti A., Tomatis R., Bianconi M., Rotola C. and Pansini R. (1983a) Prolactin-releasing activity of dermorphin, a new synthetic potent opiate-like peptide in man. J. Clin. Endocrinol. Metab. 56, 1032-1034.
22. Degli Uberti E. C., Trasforini G., Salvadori S., Margutti A., Tomatis R., Rotola C., Bianconi M. and Pansini R. (1983b) Stimulatory effects of dermorphin, a new synthetic opiate-like peptide, on human growth factor secretion. Endocrinology 37, 280-283.
23. Degli Uberti E. C., Trasforini G., Salvadori S., Margutti A., Tomatis R., Bianconi M., Rotola C. and Pansini R. (1983c) Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic opiate-like peptide, in man. J. Clin. Endocrinol. Metab. 57, 1179-1185.
24. Desarro G. B., Spagnolo C., Audino M. G., Marra R., Nisticò G. (1992) Comparative behavioural and ECoG spectrum effects of dermorphin and Ala-deltorphin given into some areas of the rat brain. Res. Comm. Sub. Abuse 13, 147-165.
25. Eager K. R., Robinson B. J., Galletly D. C., Miller J. H. (1994) Endogenous opioid modulation of hypercapnic-stimulated respiration in the rat. Resp. Physiol. 96, 13-24.
26. Erspamer V. (1992) The opioid peptides of the amphibian skin. Int. J. Devel. Neurosc. 10, 3-30.
27. Erspamer V. (1994) Bioactive secretions of the Amphibian integument. In Amphibian Biology, (Edited by Heatwole H.) p. 178-350. Surrey Beatty & Sons Publ.
28. Erspamer V. and Melchiorri P. (1983) Actions of Amphibian skin peptides on the central nervous system and the anterior pituitary. In Neuroendocrine Perspectives, Vol. 2, (Edited by Muller E. E. and McLeod R. M.) pp. 37-106. Elsevier Sci. Publ., Amsterdam.
29. Erspamer V., Melchiorri P., Falconieri Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M. and Kreil G. (1989) Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. USA 86, 5188-5192.
30. Ferrè J. P., Du Ch., Soldani G. and Ruckenbush V. (1986) Peripheral versus central components of the effects of dermorphin on intestinal motility in fed rats. Regul. Peptides 13, 109-117.
31. Feurestein G. and Faden A. I. (1983) Central autonomic effect of dermorphin in conscious tats. J. Pharmac. Exp. Ther. 226, 13-18.
32. Feurestein G. and Zukowska G. Z. (1987) Effect of dermorphin and morphine on the sympathetic and cardiovascular system in pithed rats. Neuropeptides 9, 139-150.
33. Fontani G., Vergani L., Salvadori S., Voglino N., Aloisi A. M., Portaluppi F. and Degli Uberti E. C. (1993) Effect of dermorphin on behavior and hippocampal electrical-activity in rabbits. Life Sci. 52, 323-328.
34. Giudici D., D'Urso R., Falaschi P., Negri L., Melchiorri P. and Motta M. (1984) Dermorphin stimulates prolactin secretion in the rat. Neuroendocrinol. 39, 236-244.
35. Greco B., Prevost J. and Gioanni Y. (1994) Intracerebroventricular injection of dermorphin: search for the epileptic induction thresholds. Neuroreport 5, 2169-2172.
36. Guglietta A., Irons B. J., Lazarus L. H. and Melchiorri P. (1987) Structure activity relationships of dermorphins on gastric secretion. Endocrinology 120, 2137-2143.
37. 2 opioid receptor agonists on gastric functions in the rat. Neuropharmacology 33, 977-981.
38. Improta G, Broccardo M. , Lisi A. and Melchiorri P. (1982) Neural regulation of gastric acid secretion in rats: influence of dermorphin. Regul. Peptides 3, 251-256.
39. Improta G. and Guglietta A. (1985) The rule of caudate nucleus in dermorphin-induced catalepsy in rats. Peptides 6, 161-164.
40. Intorre L., Mengozzi G., Vanni E., Grassi F. and Soldani G. (1993) The role of peripheral opioid receptor subtypes in the modulation of gastric acid secretion and plasma gastrin in dogs. Eur. J. Pharmac. 243, 265-272.
41. Jones L. S., Grooms S. Y., Salvadori S. and Lazarus L. H. (1994) Dermorphin-induced hyperexcitability in hippocampal CA3 and CA1 "in vitro." Eur. J. Pharmac. 264, 39-48.
42. Kapusta D. R., Obih J. C. and Dibona G. F. (1993) Central μ-opioid receptor mediated changes in renal-function in conscious rats. J. Pharmac. Exp. Ther. 265, 134-143.
43. Kisara K., Sakurada T., Sakurada T., Sasaki T., Sato T., Suzuki K. and Watanabe H. (1986) Dermorphin analogue containing D-kyotorphin: structure antinociceptive relationship in mice. Br. J. Pharmac. 87, 183-189.
44. Kreil G. (1994). Peptides containing a D-amino acid from frogs and molluscs. J. Biol. Chem. 269, 10967-10970.
45. Lazarus L. H. and Attila M. (1993) The toad, ugly and venomous, wears yet a precious jewel in his skin. Progress Neurobiol. 41, 473-507.
46. Lezoche E., DePasquale G., Carlini F., Procacciante F., Mariani F., Nigri R., Luminari N. and Speranza V. (1983) Effect of dermorphin, a new opiate-like peptide, on gastric secretion, exocrine pancreatic secretion and gall bladder motility in man. Regul. Peptides, Suppl 2, S139-S140.
47. Maggi C. A., Giuliani S. and Meli A. (1989) Dermorphin inhibits micturition reflex in rats at a central site of action. J. Auton. Nerv. System 26, 11-15.
48. Marchioni E., Maurelli M. and Tartara A. (1992) Quantitative EEG and autonomic patterns of synthetic peptides related to dermorphin. Neuropsychobiology 26, 81-88.
49. Melchiorri P., Falconieri Erspamer G., Erspamer V., Guglietta A., DeCastiglione R., Faoro F., Perseo G., Piani S. and Santangelo F. (1982) Synthetic peptides related to the dermorphins. II. Synthesis and biological activities of new analogues. Peptides 3, 745-748.
50. Melchiorri P., Negri L., Falconieri Erspamer G., Severini C., Corsi R., Soaje M., Erspamer V. and Barra D. (1991) Structure-activity relationships of the delta-opioid selective agonists, deltorphins. Eur. J. Pharmac. 195, 201-207.
51. Meyer M. E. and Mclaurin B.I. (1995) DALDA (H-Tyr-D-Arg-Phe-Lys-NH2), a potent μ,-opioid peptide agonist, affects various patterns of locomotor activities. Pharmac. Biochem. Rehav. 61, 149-151.
52. Mignogna G., Severini C., Simmaco M., Negri L., Falconieri Erspamer G., Kreil G. and Barra D. (1992) Identification and characterization of two dermorphins from skin extracts of the Amazonian frog Phyllomedusa bicolor. FEBS 302, 151-154.
53. Mitsuma T., Noginori T. and Chaya A. (1985) Dermorphin inhibits basal and cold-induced thyrotropin secretion in rats. Endocrin. Exper. 19, 83-90.
54. Montecucchi P. C., de Castiglione R. and Erspamer V. (1981b) Identification of dermorphin and Hyp-dermorphin in skin extract of the Brazilian frog Phyllomedusa rohdei. Int. J. Peptide Prot. Res. 17, 316-321.
55. Montecucchi P. C., de Castiglione R., Piani S., Gozzini L., and Erspamer V. (1981a) Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin extracts of Phyllomedusa sauvagei. Int. J. Peptide Prot. Res. 17, 275-283.
56. Mor A., Delfour A., Amiche M., Sagan S., Nicolas P., Grassi J. and Pradelles Ph. (1989) Dermorphin and related peptides in rat tissues. Neuropeptides 13, 51-57.
57. Mor A., Delfour A. and Nicolas P. (1991) Identification of a D-Ala-containing polypeptide precursor for the peptide opioid, dermorphin. J. Biol. Chem. 266, 6264-6270.
58. Mor A., Pradelles Ph., Delfour A., Montagne J. J., Quintere F. L., Conrath M. and Nicolas P. (1990) Evidence for pro-dermorphin processing products in rat tissues. Biochem. Biophys. Res. Commun. 170, 30-38.
59. Mosberg H. I., Heyl D. L., Haaseth R. C, Omnaas J. R., Medzkihrasky F. and Smith C. B. (1990) Dermorphin-like tetrapeptides with δ-opioid receptor activity. 3. Effect of residue 3 modidfication on "in vitro" opioid activity. Mol. Pharmac. 38, 924-928.
60. Nader W. and Barret J. (1989) Effects of corticotropin-releasing factor, tuftsin and dermorphin on behavior of squirrel monkeys maintained by different events. Peptides 10, 1199-1204.
61. 4]dermorphin (1-4) in the rat. Pharmac. Biochem. Behav. 24, 27-31.
62. Negri L., Falconieri Erspamer G., Severini C., Melchiorri P. and Erspamer V. (1992) Dermorphin related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two μ-opioid receptor subtypes which modulate antinociception and catalepsy, in the rat. Proc. Natl. Acad. Sci. USA 89, 7203-7207.
63. Negri L. and Improta G. (1984) Distribution and metabolism of dermorphin in rats. Pharmac. Res. Commun. 16, 1183-1194.
64. 7]dermorphin, a naturally occurring peptide with high affinity for μ-opioid receptors. Br. J. Pharmac. 114, 57-66.
65. Negri L., Melchiorri P., Falconieri Erspamer G. and Erspamer V. (1981) Radioimmunoassay of dermorphin-like peptides in mammalian and non-mammalian tissues. Peptide 2, 45-49.
66. Nisticò G., Desarro G. B., Rotiroti D., Melchiorri P. and Erspamer V. (1981) Comparative effets of β-endorphin and dermorphin on behaviour, electrocortical activity and spectrum power in chicks after intraventricular administration. Res. Commun. Physiol. Psychiat. Behaviour 6, 351-363.
67. 2-receptor-mediated regulation of heart-rate in the conscious rat. Neuropharmacology 31, 777-782.
68. Paakkari P., Paakkari I., Landes P., Siren A. L., Feuerstein G. (1993a) Respiratory mu-opioid and benzodiazepine interactions in the unrestrained rat. Neuropharmacology 32, 323-329.
69. 1 receptor-mediated effect. J. Pharmac. Exp. Ther. 252, 235-252.
70. 1-receptors. J. Pharmac. Exp. Ther. 266, 544-550.
71. Perfumi M., DeCaro G., Massi M. and Venturi F. (1986) Inhibition of angiotensin II induced drinking by dermorphin given into the SFO or into the lateral ventricle of intact or SFP-lesioned rats. In The Physiology of Thirst and Sodium Appetite (Edited by Decaro G., Epstein A. N. and Massi M.) pp 257-263. Plenum Publish. Corp.
72. Portolano F., Filippelli A., Marrazzo R., Susanna V., Russo S., Stella L., Losasso C., Molinaro L., Agrisani M., Falzarano C. and Marmo E. (1991a) Cardiovascular and respiratory effects of dermorphin in rats. Res. Commun. Clin. Pathol. Pharmac. 71, 131-152.
73. Portolano F., Marrazzo R., Matera S., De Novellis V., Marmo M. and Rossi F. (1991b) Opiate peptidergic neurotransmission and cardiovascular and respiratory apparatus: Experimental research with endorphin and dermorphin on normotensive and hypertensive rats. Curr. Ther. Res. 50, 625-634.
74. Puglisi Allegra S., Castellano G., Fillibeck U., Oliverio A. and Melchiorri P. (1982) Behavioural data of dermorphin in mice. Eur. J. Pharmac. 82, 223-227.
75. Richter K., Egger R. and Kreil G. (1987) D-Alanine in the frog skin peptide dermorphin is derived from L-Alanine in the precursors. Science 238, 200-202.
76. Richter K., Egger R., Negri L., Corsi R., Severini C. and Kreil G. (1990) cDNAs encoding [D-Ala2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides. Proc. Natl. Acad. Sci. USA 87, 4836-4839.
77. Rossi A., Di Salle E., Briatico G., Arcari G., DeCastiglione R. and Perseo G. (1983) Antinociceptive, prolactin-releasing and intestinal motility inhibiting activities of dermorphin and analogues after subcutaneous administration in the rat. Peptides 4, 477-580.
78. Rotiroti D., Germanà G., Nisticò G., Melchiorri P. and Erspamer V. (1984) Stimulation of crop sac and pituitary lactotrophs after intraventricular administration of dermorphin in pigeons. Gen. Comp. Endocrinol. 56, 24-31.
79. Sakurada S., Chaki K., Watanabe H., Nakata N., Sakurada T., Kisara K. and Suzuki K. (1992) Antinociceptive mechanism of [D-Arg2]dermorphin tripeptide analogs. J. Pharmac. Exp. Ther. 263, 793-799.
80. Sakurada S., N. Nakata, Sakurada T., Chaki K., Kawamura S., Kisara K. and Suzuki K. (1993) Tolerance and cross-tolerance to the antinociceptive effects of [D-Arg2]dermorphin tripeptide analogs and morphine. Neuropharmacology 32, 689-693.
81. Sander G. E. and Giles T. D. (1982) Enkephalin analogs and dermorphin in the conscious dog: structure-activity relationships. Peptides 3, 1017-1021.
82. Sandrini G., Degli Uberti E., Salvadori S., Margutti A., Trasforini G., Tomatis R., Nappi G. and Pansini R. (1986) Dermorphin inhibits spinal nociceptivc flexion reflex in humans. Brain Res. 371, 364-367.
83. Sasaki Y., Hosono M., Matsui M. , Fujita N., Suzuki K., Sh. Sakurada, Sakurada T. and Kisara K. (1985) On the degradation of dermorphin and [D-Arg2]dermorphin analogs by a soluble rat brain extract. Biochem. Biophys. Res. Commun. 130, 964-970.
84. Sato T., Sakurada S., Sakurada T., Furuta S., Chaki K., Kisara K., Sasaki Y. and Suzuki K. (1987) Opioid activities of D-Arg substituted tetrapeptides, J. Pharmac. Exp. Ther. 242, 651-659.
85. Sato T., Sakurada S., Sakurada T., Kisara K. and Suzuki K. (1992) Comparison of opioid properties between D-Arg-containing dipeptides and tetrapeptides. Biochem. Pharmac. 43, 717-723.
86. Scalia S., Salvadori S., Marastoni M., Bortolotti F. and Tomatis R. (1986) Reversed-phase HPLC study on the in vitro enzymatic degradation of dermorphin. Peptides 7, 247-251.
87. Schiller P. W., Nguyen T. D., Chung N. N. and Lemieux C. (1989) Dermorphin analogues carrying an increased positive ner charge in their "message" domain display extremely high μ-opioid receptor selectivity. J. Med. Chem. 32, 698-703.
88. Seethaler G., Chaminade M., Vlasak R., Ericsson M., Griffiths G., Toffoletto O., Rossier J., Stunnenberg H. and Kreil G. (1991) Targeting of frog prodermorphin to the regulated secretory pathway by fusion to proenkephalin. J. Cell. Biol. 114, 1125-1133.
89. Sivanandaiah K. M., Gurusiddappa S. and Babu V. V. (1989) Synthesis and biological studies of dermorphin and its analogs substituted at position 5 and 7. J. Peptide Protein Res. 33, 463-467.
90. Stevens C. V. and Yaksh T. (1986) Spinal action of dermorphin, an extremely potent opioid peptide from frog skin. Brain Res. 385, 303-304.
91. Sullivan A. F. and Dickenson A. H. (1988) Electrophysiological studies on the spinal effects of dermorphin, an endogenous mu-opioid agonist. Brain. Res. 481, 182-185.
92. Surrat C. K., Johnson P. S., Moriwaki A., Seidleck B. K., Blaschak C. J., Wang J. B. and Uhl G. R. (1994) μ Opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269, 20548-20553.
93. Tseu K., Wang F. S., Wang S. H. and Tang Y. Q. (1985) Dermorphinke-like immunoreactivity in guinea pig and rat stomach. Neuropeptide 5, 449-452.
94. Ukai M., Mori K., Hashimoto S., Kobayashi T., Sasaki Y. and Kameyama T. (1993) Tyr-D-Arg-Phe-β-Ala-NH2, a novel dermorphin analog, impairs memory consolidation in mice. Eur. J. Pharmac. 239, 237-240.
95. Wang J. B., Imai Y., Eppler C. M., Gregor P., Spivak C. E. and Uhl G. R. (1993) μ opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. 90, 10230-10234.